Monogram Orthopaedics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Monogram Orthopaedics generated cash of -$13,542,509, which is less than the previous year. Cash used in financing activities reached the amount of $16,727,805 last year. Net change in cash is therefore $3,120,383.
Cash Flow
| 2017 | -619.37K | -151.54K | 1.00M |
|---|---|---|---|
| 2018 | -306.86K | -154.91K | 1.14M |
| 2019 | -1.04M | -5.36K | 2.45M |
| 2020 | -5.40M | -1.33M | 10.00M |
| 2021 | -9.16M | -1.00M | 10.12M |
| 2022 | -8.41M | -241.20K | 13.59M |
| 2023 | -13.54M | -64.91K | 16.72M |
MGRM Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 10.46M | 5.53M | 5.58M | 2.31M | 922.10K | 235.88K | 0 |
Operating activities | |||||||
Net income | -13.74M | -13.69M | -11.81M | -9.06M | -1.79M | -712.26K | -658.99K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 412.33K | 386.68K | 321.98K | 95.69K | 31.76K | 30.95K | 13.35K |
Stock-based compensation expense | 1.55M | 743.27K | 205.62K | 2.16M | 614.87K | 0 | 382 |
| Deferred income tax benefit | 1.55M | 743.27K | 205.62K | 2.16M | 614.87K | 0 | 382 |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | -364.99K | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 1.79M | 214.13K | 266.21K | -59.03K | -15.63K | 233.20K | 2.27K |
Cash generated by operating activities | -13.54M | -8.41M | -9.16M | -5.40M | -1.04M | -306.86K | -619.37K |
Investing activities | |||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -64.91K | -241.20K | -1.00M | -1.33M | -5.36K | -154.91K | -151.54K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -64.91K | -241.20K | -1.00M | -1.33M | -5.36K | -154.91K | -151.54K |
Financing activities | |||||||
Common Stock Issued | 15.33M | 13.59M | 10.12M | 10.76M | 489 | 0 | 2.80K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -840K | -76K | 0 | 1.00M |
Cash used in financing activities | 16.72M | 13.59M | 10.12M | 10.00M | 2.45M | 1.14M | 1.00M |
Net Change In Cash | 3.12M | 4.93M | -51.03K | 3.26M | 1.39M | 686.22K | 235.88K |
Cash at end of period | 13.58M | 10.46M | 5.53M | 5.58M | 2.31M | 922.10K | 235.88K |
| Data source |